Skip to Content

Pfizer STN 25 mg (Sutent 25 mg)

Generic Name: sunitinib

Pill with imprint Pfizer STN 25 mg is Brown & Orange, Capsule-shape and has been identified as Sutent 25 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.

Sutent is used in the treatment of renal cell carcinoma; gastrointestinal stromal tumor; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Pfizer STN 25 mg

Sutent

Generic Name
sunitinib
Imprint
Pfizer STN 25 mg
Strength
25 mg
Color
Brown & Orange
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors, Vegf/vegfr inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC)
00069-0770
Inactive Ingredients
mannitol, croscarmellose sodium, povidone k25, magnesium stearate, titanium dioxide, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, shellac, propylene glycol, sodium hydroxide, potassium hydroxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.